Aging-related Inflammation in HIV-infected Patients Completed Phase 4 Trials for Raltegravir (DB06817)

IndicationStatusPhase
DBCOND0078830 (Aging-related Inflammation in HIV-infected Patients)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02577042Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based RegimenTreatment